Metabolic-Fit / 100
Eve review
One flat $195/mo price for compounded GLP-1 therapy, injection or sublingual, regardless of which molecule — plus a brand-name lane (Ozempic, Wegovy, Mounjaro) for mothers who want an on-label pen instead. Its full pricing only renders inside the signup flow, and the state list isn't published.
then $195/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Eve at a glance
- Semaglutide
- $195/mo flat
- Tirzepatide
- $195/mo flat
- Coverage
- Multiple states (not fully enumerated — confirm yours before signing up)
- Brand-name
- Yes
How we scored Eve
Each factor is scored from Eve's real pricing, disclosures and oversight, then combined into the 49/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.tryeve.co
Re-verified live 2026-08-05: site title, the semfirst99/semfirst$99 promo code string, and the FDA compounding disclaimer all match the prior record exactly, with no drift. The static marketing page only exposes a $0/$99 promo fragment — the full per-dose pricing catalog is gated behind the go.tryeve.co signup flow (a client-rendered funnel), consistent with the standing SPA-pricing caveat on this network. LegitScript ID 42862417 confirmed present in the footer. Full state list, named pharmacy, 503A/503B designation, medical director, and governing-law venue are NOT disclosed on the public site.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 → $195 | Injection, either moleculeOne flat $195/mo price covers compounded semaglutide OR tirzepatide — Eve doesn't price the two molecules separately. Promo code semfirst99 drops the first month to $99; the standing rate is $195. |
| Compounded tirzepatide | $99 → $195 | Injection, either moleculeSame flat $195/mo program as the semaglutide row — one price regardless of which molecule is prescribed. $99 first month with code semfirst99. |
| Oral semaglutide | $195 | SublingualOral/sublingual compounded semaglutide at the same $195/mo flat rate as the injection. |
| Brand semaglutide | $1399 | Ozempic® |
| Brand semaglutide | $1699 | Wegovy® |
| Brand tirzepatide | $1399 | Mounjaro® |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Eve's public disclosures at last review and change often; confirm the current number on Eve's own site.
What we like
- One flat $195/mo rate covers either molecule — no separate, higher tirzepatide price to plan around
- A genuine oral/sublingual compounded option at the same flat price as the injection
- Also offers brand-name Ozempic, Wegovy, and Mounjaro for mothers who want an FDA-approved pen
- $0 due unless a licensed physician actually approves you — you aren't charged for a denial
The caveats
- No published state list — coverage is confirmed only after you start intake or relocate
- Full per-dose pricing is gated behind the signup application, not visible on the public marketing page
- Named pharmacy, 503A/503B designation, and medical director are not disclosed anywhere public
- The $99 first-month price is promotional; budget for $195/mo starting month two
Eve for mothers: our verdict
One flat $195/mo price for compounded GLP-1 therapy, injection or sublingual, regardless of which molecule — plus a brand-name lane (Ozempic, Wegovy, Mounjaro) for mothers who want an on-label pen instead. Its full pricing only renders inside the signup flow, and the state list isn't published. The advertised entry is $99, but the standing rate settles near $195/month — so read the headline as a starting offer, not the monthly cost.
We weigh Eve the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Eve actually costs
- Compounded semaglutide — Injection, either molecule: $99 to start, then $195/mo
- Compounded tirzepatide — Injection, either molecule: $99 to start, then $195/mo
- Oral semaglutide — Sublingual: $195/mo
- Brand-name semaglutide — Ozempic®: $1399/mo
- Brand-name semaglutide — Wegovy®: $1699/mo
- Brand-name tirzepatide — Mounjaro®: $1399/mo
That lands within a few dollars of the ~$175/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
The medications Eve prescribes
Eve prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Eve fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Eve is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a single, predictable price no matter which molecule they end up on, and who don't mind confirming state coverage directly before paying.
Alternatives to Eve
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Eve
Head-to-head & alternatives
Eve, answered
- Does Eve charge different prices for semaglutide and tirzepatide?
- No — that's the one thing that sets it apart. Eve prices compounded GLP-1 therapy at a single flat $195/mo regardless of which molecule your clinician prescribes, injection or sublingual. A promo code (semfirst99) knocks the first month to $99; the ongoing rate is $195.
- Which states does Eve serve?
- Eve doesn't publish a state list. Its own copy only says the plan will 'follow you if you relocate to a state we currently serve' — reassuring for continuity, but it means you can't check coverage before you start intake. Confirm your state directly before paying.
- Is Eve's pricing actually public?
- Only partly. The static marketing page shows a $0/$99 promotional fragment, but the real per-dose price list only renders inside Eve's separate signup application (go.tryeve.co) — a client-rendered flow that a plain page-load doesn't show. Expect to start intake before you see the full catalog.
Pricing, states and verification reflect Eve's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.